4 Pharmaceutical Stocks to Buy Now
InvestorPlace
J&J, Up 25% YTD, Shrugs Off Risperdal Suits
Yahoo/YCharts
Can Johnson & Johnson Navigate Its Public Relations Tightrope?
Wall St. Cheat Sheet
ASCO '13 Preview: Gilead's Big Cancer Debut
TheStreet.com

